Anhui Zhifei Longcom COVID-19 vaccine |
ZF2001; ZIFIVAX; ZF-UZ-VAC 2001 |
Protein subunit |
Has not been authorized |
IM |
Monodose vial (0.5 mL) |
No |
Aluminium hydroxide-based adjuvant |
Not yet available |
Not yet available |
Not yet available |
Not yet available |
Not yet available |
Not yet available |
Bharat Biotech COVID-19 vaccine (EUL) |
BBV152; Covaxin |
Inactivated virus |
Individuals aged 18 years and over, pregnancy (if the benefits of vaccination to the pregnant person outweigh the potential risks) and breastfeeding. |
IM |
Monodose (0.5 mL) or multidose vials of 5, 10 and 20 doses (2.5, 5, and 10 mL, respectively). |
No |
IMDG (Imidazo quinolin gallamide) and alum |
Phenoxy ethanol |
9 months |
No |
No |
9 months |
Maximum 6 hours (2 to 8°C) |
CanSino COVID-19 vaccine |
Ad5-nCoV; Convidecia; PakVac |
Viral vector (non-replicating) |
Individuals aged 18 years and over, pregnancy (if the benefits of vaccination to the pregnant person outweigh the potential risks) and breastfeeding. |
IM |
Monodose (0.5 mL) or multidose vials of 3 doses (1,5 mL). |
No |
No |
No |
12 months |
No |
No |
12 months |
Maximum 6 hours (2 to 8°C) |
AstraZeneca/Oxford; SK BIO; Serum Institute of India (SII) COVID-19 vaccine (EUL) |
ChAdOx1-S [recombinant]; Vaxzevria in Europe (formerly AZD1222 and ChAdOx1); Covishield in India |
Viral vector (non-replicating) |
Individuals aged 18 years and over, pregnancy (if the benefits of vaccination to the pregnant person outweigh the potential risks) and breastfeeding |
IM |
Multidose vials of 2, 8 or 10 doses (0.5 mL each). Vial volume: 1, 4, or 5 mL, respectively. |
No |
No |
No |
Vaxzevria: 6 months
Covishield: 9 months |
No |
No |
Vaxzevria: 6 months
Covishield: 9 months |
Maximum 6 hours (2 to 8°C) |
Gamaleya COVID-19 vaccine |
Sputnik V; Gam-COVID-Vac; Adeno-based (rAd26-S+rAd5-S)/ Sputnik light |
Viral Vector (non-replicating) |
Has not been authorized |
IM |
Sputnik V: multidose vial of 5 doses (0.5 mL each). Vial volume: 2.5 mL.
Sputnik Light: multidose vial of 5 doses (0.5 mL each). Vial volume: 2.5 mL. |
No |
No |
No |
3 months |
No |
6 months (-18°C or below) |
No |
Maximum 2 hours (15 °C to 25 °C) |
Instituto Finlay COVID-19 vaccine |
FINLAY-FR-2, SOBERANA 02; SOBERANA 02 ST; SOBERANA PLUS; SOBERANA PLUS ST |
Protein subunit |
Has not been authorized |
IM |
Soberana 02 and Soberana Plus: multidose vial of 10 doses (0.5 mL each). Vial volume: 5 mL. Every 10-dose vial contains thiomersal;
Soberana 02 ST and Soberana plus ST: monodose vial without thimerosal. |
No |
Aluminium hydroxide-based adjuvant |
Soberana 02 and Soberana Plus: Thiomersal |
Soberana 02 and Soberana 02 ST: 6 months
Soberana Plus and Soberana Plus ST: 4 months |
No |
No |
Soberana 02 and Soberana 02 ST: 6 months
Soberana Plus and Soberana Plus ST: 4 months |
Soberana 2 and Soberana Plus: Maximum 6 hours (2 to 8°C)
Soberana 2 ST and Soberana Plus ST: Use immediately |
Janssen COVID-19 vaccine (EUL) |
JNJ-78436735; Ad26.COV2-S (recombinant) |
Viral vector (non-replicating) |
Individuals aged 18 years and over, pregnancy (if the benefits of vaccination to the pregnant person outweigh the potential risks) and breastfeeding |
IM |
Multidose vial of 5 doses (0.5 mL each). Vial volume: 2.5 mL. |
No |
No |
No |
24 months |
No |
24 months |
WHO: 4.5 months. EMA: 11 months. |
WHO: Maximum 6 hours (2 to 8°C)
EMA: 3 hours (maximally 25°C) |
Moderna COVID-19 vaccine (EUL) |
mRNA-1273; Elasomeran; Spikevax, TAK-919 |
RNA-based vaccine |
Individuals aged 12 years and over, pregnancy and breastfeeding. |
IM |
Multidose vials of 10 or 15 doses (0.5 mL each). Vial volume: 5, or 7.5 mL, respectively. |
No |
Lipid nanoparticle (LNP) |
No |
7-9 months |
No |
7-9 months (-20 ± 5°C) |
1 month |
Maximum 6 hours (2 to 25 °C) |
Novavax/Serum Institute of India (SII) COVID-19 vaccine |
NVX-CoV2373; COVOVAX; NUVAXOVID |
Protein subunit |
Individuals aged 18 years and over, pregnancy (if the benefits of vaccination to the pregnant person outweigh the potential risks) and breastfeeding |
IM |
Multidose vial of 10 doses (0.5 mL each). Vial volume: 5 mL. |
No |
Matrix-M1 |
No |
9 months |
No |
No |
9 months |
Monodose: Use immediately**
Multidose: Maximum 6 hours (2 to 8°C) |
Pfizer-BioNTech COVID-19 vaccine (EUL) |
2BNT162b2; Tozinameran; Comirnaty |
RNA-based vaccine |
Individuals aged 5 years and over, pregnancy and breastfeeding. |
IM |
Concentrate for dispersion for injection: multidose vial of 6 doses after dilution (0.3 or 0.2 mL each).
'Ready to use' formulation: multi-dose vial. One dose (0.3 mL). |
Concentrate for dispersion for injection: Sodium Chloride.
'Ready to use' formulation: No |
Lipid nanoparticle (LNP) |
No |
9 months |
9 months |
2 weeks |
31 days (undiluted) |
Maximum 6 hours (2 to 8°C) |
Sinopharm/BIBP (Beijing Institute of Biological Products) COVID-19 vaccine (EUL) |
Inactivated SARS-CoV-2-vaccine (Vero cell); BBIBP-CorV; adsorbed COVID-19 vaccine |
Inactivated virus |
Individuals aged 18 years and over, pregnancy (if the benefits of vaccination to the pregnant person outweigh the potential risks) and breastfeeding |
IM |
Monodose (0.5 mL) or multidose vial of 2 or 5 doses (1, or 2.5 mL). |
No |
Aluminium hydroxide-based adjuvant |
No |
24 months |
No |
No |
24 months |
Monodose: Use immediately**
Multidose: Maximum 6 hours (2 to 8°C) |
Sinopharm/WIBP (Wuhan Institute of Biological Products) COVID-19 vaccine |
Inactivated SARS-CoV-2-vaccine (Vero cell); WIBP-CorV; adsorbed COVID-19 vaccine |
Inactivated virus |
Has not been authorized |
IM |
Monodose vial (0.5 mL) |
No |
Aluminium hydroxide-based adjuvant |
No |
6 months |
No |
No |
6 months |
Monodose: Use immediately** |
Sinovac COVID-19 vaccine (EUL) |
CoronaVac; adsorbed COVID-19 vaccine |
Inactivated virus |
Individuals aged 18 years and over, pregnancy (if the benefits of vaccination to the pregnant person outweigh the potential risks) and breastfeeding |
IM |
(a) Monodose (0.5 mL) or multidose vial of 2 doses (vial volume: 1 mL), or (b) monodose in a prefilled syringe. |
No |
Aluminium hydroxide-based adjuvant |
No |
12 months |
No |
No |
12 months |
Monodose: Use immediately**
Multidose: Maximum 6 hours (2 to 8°C) |
Vector Institute COVID-19 vaccine |
EpiVacCorona; EpiVakKorona |
Protein subunit |
Has not been authorized |
IM |
Not yet available |
No |
No |
No |
Not yet available |
Not yet available |
Not yet available |
Not yet available |
Not yet available |
CIGB (Centro de Ingeniería Genética y Biotecnología) COVID-19 vaccine |
Abdala; CIGB-66 |
Protein subunit |
Has not been authorized |
IM |
Multidose vial of 10 doses (0.5 mL each). Vial volume: 5 mL. |
No |
Aluminium hydroxide-based adjuvant |
Thiomersal |
6 months |
No |
No |
6 months |
Maximum 6 hours (2 to 8°C) |